Brief: Takeda Pharmaceutical's Qdenga (Tak-003) Becomes First Dengue Vaccine To Be Approved In India- Statement
20/07/2026 06:45
BRIEF-Takeda Pharmaceutical's Qdenga (Tak-003) Becomes First Dengue Vaccine To Be Approved In India- Statement July 20 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T:
TAKEDA PHARMACEUTICAL'S QDENGA (TAK-003) BECOMES FIRST DENGUE VACCINE TO BE APPROVED IN INDIA- STATEMENT
Further company coverage: 4502.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsTakeda launches sleep disorder pill in the US after DEA clearance removes final hurdle (updated)
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)